SORRISO PHARMACEUTICALS
Sorriso Pharmaceuticals is a biotechnology company advancing a pipeline of disease-modifying antibodies for the treatment of inflammatory disease, including Crohn’s disease and ulcerative colitis. The Sorriso platform generates potent antibodies that can be delivered orally and are designed to maintain activity throughout the intestinal system. The company was founded in 2020 and is based in San Diego, California.
SORRISO PHARMACEUTICALS
Industry:
Biotechnology Pharmaceutical Therapeutics
Founded:
2020-01-01
Address:
San Diego, California, United States
Country:
United States
Website Url:
http://www.sorrisopharma.com
Status:
Active
Email Addresses:
[email protected]
Total Funding:
31 M USD
Similar Organizations
AZTherapies
AZTherapies is a clinical stage biotech company developing breakthrough treatments for neuroinflammation-related diseases.
Current Employees Featured
Founder
Investors List
Arix Bioscience
Arix Bioscience investment in Series A - Sorriso Pharmaceuticals
New Enterprise Associates
New Enterprise Associates investment in Series A - Sorriso Pharmaceuticals
Official Site Inspections
http://www.sorrisopharma.com
- Host name: cloudproxy10026.sucuri.net
- IP address: 192.124.249.26
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
